Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Sprout Health vs WeightRx

Sprout Health
Graded #6

Higher grade

vs+14.300000000000011
WeightRx
Graded #85

Lower grade

The verdict

Sprout Health takes it — 86.4/100 to 72.1/100.

Sprout Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A LegitScript-certified desk that pairs low-cost compounded semaglutide and tirzepatide with a real brand-name Wegovy and Zepbound path — and a near-frictionless, often visit-free start.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueWeightRx +1
90
91
Dose & formulationSprout Health +18
82
64
Clinical oversightSprout Health +6
88
82
Labs & monitoringSprout Health +39
92
53
FulfillmentSprout Health +13
78
65
Contract termsSprout Health +29
84
55
Sprout Health · left barWeightRx · right bar

The numbers

MetricSprout HealthWeightRx
WeighScore86.4/10072.1/100
GradeBC
Scorecard rank#6#85
Semaglutide$149/mo$250/mo (compounded)
Tirzepatide$199/mo$83/mo (term not published, compounded)
CoverageNot disclosedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Sprout Health

Graded #6 · B

Strengths

  • LegitScript-certified with a listed address and contact line
  • Both compounded ($149 semaglutide / $199 tirzepatide) and a genuine brand-name Wegovy/Zepbound route
  • Low-friction intake — no labs and often no telehealth visit required

Where it loses points

  • Compounded semaglutide and tirzepatide are not FDA-approved
  • No oral or sublingual route — injectable only
  • Thin transparency — no named medical director, and state availability is quiz-gated
  • "No labs, no visit" convenience also means lighter clinical oversight
WeightRx

Graded #85 · C

Strengths

  • The tirzepatide figure is published up front, and it is genuinely low against the field
  • Both molecules are offered
  • No membership charge is advertised alongside the medication rate

Where it loses points

  • The $83 monthly rate is advertised as '$83/month ($997/year)', which is twelve months of it — no month-to-month rate is separately published, and the terms state that a rate is locked for its full term
  • Both product pages linked from the homepage return 404, so the plan terms cannot be read before intake
  • Six- and twelve-month plans are non-refundable, and eligible refunds carry a 5% processing fee
  • No dose strength is published anywhere, so what the $83 buys is not stated
  • The named operator is Twist G Marketing, LLC rather than a clinical entity, and the terms carry a binding arbitration and class-action waiver

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard